2020 IPO

AbCellera Biologics Stock

Antibody therapeutics

Sign up today and learn more about AbCellera Biologics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About AbCellera Biologics Stock

AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.

Funding History

September 2013$0
August 2014$0
January 2017$0
April 2017$818K
September 2018$10.0M
March 2019$4.8M

Management

Co-Founder

Kevin Heyries

Co-Founder & Director

VĂ©ronique Lecault

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo